RxDoctor Payments Data

James Wright, DO

Family Medicine · Greenville, MSNPI 1053390781

Payments from drug & device makers

$956in general payments, 2019–2025

Across 54 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$358
  • Baxter Healthcare$66
  • Pfizer$64
  • Novartis$62
  • Merck$47
  • Boehringer Ingelheim$45
  • plus $315 from 13 others

What the payments were for

  • Food & beverage$93598%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$956 in reported general payments places this provider in the 55th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$53,989
Medicare patients
205
Services billed
676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin114$81,450
OzempicSemaglutide65$75,137
EliquisApixaban97$66,687
MounjaroTirzepatide61$65,543
LinzessLinaclotide52$43,306
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,113$40,799
Tresiba Flextouch U-100Insulin Degludec28$23,605
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$17,968
JanuviaSitagliptin Phosphate20$15,514
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$15,028
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen246$11,106
Repatha SureclickEvolocumab15$9,975
Fentanyl23$7,771
FarxigaDapagliflozin Propanediol13$7,502
Combivent RespimatIpratropium/Albuterol Sulfate15$7,371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$45$95,090141 claims
Novo NordiskOzempic$32$75,13765 claims
PfizerEliquis$64$66,68797 claims
Lilly USA, LLCMounjaro$31$65,54361 claims
AbbVieLinzess$358$43,30652 claims
MerckJanuvia$47$15,51420 claims
AstraZenecaFarxiga, Symbicort$39$12,35734 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$21$5,88325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Greenville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →